Regional anesthesia. unspecified symptoms and signs involving the nervous and musculoskeletal systems
Conditions
Interventions
Intervention 1: group 1, No history of opium addiction who receive intrathecal bupivacaine along with 1 mL saline as placebo. Intervention 2: group 2, No history of opium addiction who receive intrath
Placebo
Treatment - Drugs
group 1, No history of opium addiction who receive intrathecal bupivacaine along with 1 mL saline as placebo.
group 2, No history of opium addiction who receive intrathecal bupivacaine along with 1 mL sufentanil (5 µg).
group 3, Positive history of opium addictions who receive intrathecal bupivacaine along with 1 mL saline as placebo.
group 4, Positive history of opium addictions who receive intrathecal bupivacaine along with 1 mL sufentanil (5 µg).
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Inclusion criteria: ASA physical status I and II scheduled for orthopedic surgery less than 2 hours. Exclusion criteria: Hepatic or Renal failure; Heart diseases; History of drug allergy; Morbid obesity; History of postoperative nausea and vomiting (PONV); history of motion sickness; Patients with Chronic pains.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Block Time. Timepoint: Every 5 minutes. Method of measurement: Pinprick test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Post-operative pain. Timepoint: every 4 hours. Method of measurement: Numeric Rating Score(NRS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ali Movafegh
Department of Anesthesiology, Tehran University of Medical Sciences
Outcome results
None listed